Photo of Niramol Savaraj

View Scopus Profile

Niramol Savaraj

Research Professor

  • 7950 Citations
1977 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Niramol Savaraj is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Overcoming BRAF and MEK Inhibitors Resistance in Advanced Melanoma

Savaraj, N.

National Institutes of Health

1/1/16 → 12/31/19

Project: Research project

    • Research Output

    Nivolumab to pembrolizumab switch induced a durable melanoma response: A case report

    Lepir, T., Zaghouani, M., Roche, S. P., Li, Y. Y., Suarez, M., Irias, M. J. & Savaraj, N., Jan 1 2019, In : Medicine. 98, 2, p. e13804

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Phase 2 study of pembrolizumab and circulating biomarkers to predict anticancer response in advanced, unresectable hepatocellular carcinoma

    Feun, L. G., Li, Y. Y., Wu, C., Wangpaichitr, M., Jones, P. D., Richman, S. P., Madrazo, B., Kwon, D., Garcia-Buitrago, M., Martin, P., Hosein, P. J. & Savaraj, N., Jan 1 2019, In : Cancer.

    Research output: Contribution to journal › Article

    • 3 Scopus citations

    A Kinetic Dearomatization Strategy for an Expedient Biomimetic Route to the Bielschowskysin Skeleton

    Scesa, P., Wangpaichitr, M., Savaraj, N., West, L. & Roche, S. P., Jan 1 2018, (Accepted/In press) In : Angewandte Chemie - International Edition.

    Research output: Contribution to journal › Article

    • 5 Scopus citations

    Decreased argininosuccinate synthetase expression in thai patients with cholangiocarcinoma and the effects of adi-peg20 treatment in cca cell lines

    Roeksomtawin, S., Navasumrit, P., Waraprasit, S., Parnlob, V., Sricharunrat, T., Bhudhisawasdi, V., Savaraj, N. & Ruchirawat, M., Aug 1 2018, In : Oncology Letters. 16, 2, p. 1529-1538 10 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Argininosuccinate synthetase 1 (ASS1) is a common metabolic marker of chemosensitivity for targeted arginine- and glutamine-starvation therapy

    Long, Y., Tsai, W. B., Wang, D., Hawke, D. H., Savaraj, N., Feun, L. G., Hung, M. C., Chen, H. H. W. & Kuo, M. T., Mar 1 2017, In : Cancer Letters. 388, p. 54-63 10 p.

    Research output: Contribution to journal › Article

    • 5 Scopus citations